You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 13, 2025

Drug Price Trends for CLOTRIMAZOLE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for CLOTRIMAZOLE

Average Pharmacy Cost for CLOTRIMAZOLE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug NameNDCPrice/Unit ($)UnitDate
CLOTRIMAZOLE 1% SOLUTION 51672-1260-03 0.76926 ML 2025-03-19
CLOTRIMAZOLE 1% SOLUTION 52817-0800-30 0.76926 ML 2025-03-19
CLOTRIMAZOLE 1% SOLUTION 70010-0229-54 2.65584 ML 2025-03-19
CLOTRIMAZOLE 1% SOLUTION 51672-2037-01 2.65584 ML 2025-03-19
CLOTRIMAZOLE-BETAMETHASONE LOT 51672-1308-03 2.67938 ML 2025-03-19
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Best Wholesale Price for CLOTRIMAZOLE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)UnitDatesPrice Type
CLOTRIMAZOLE 1% SOLN,TOP Golden State Medical Supply, Inc. 51672-1260-03 30ML 34.97 1.16567 ML 2023-06-23 - 2028-06-14 FSS
CLOTRIMAZOLE 10MG TROCHE Golden State Medical Supply, Inc. 00054-4146-22 70 11.89 0.16986 EACH 2023-06-15 - 2028-06-14 FSS
CLOTRIMAZOLE 1% CREAM,USP,TOP Golden State Medical Supply, Inc. 51672-1275-01 15GM 11.43 0.76200 GM 2023-06-15 - 2028-06-14 FSS
CLOTRIMAZOLE 1% CREAM,TOP Golden State Medical Supply, Inc. 51672-2002-02 30GM 6.39 0.21300 GM 2023-06-23 - 2028-06-14 FSS
CLOTRIMAZOLE 1% CREAM,TOP Golden State Medical Supply, Inc. 51672-2002-02 30GM 6.00 0.20000 GM 2023-06-15 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Unit>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 5 of 5 entries

Clotrimazole Market Analysis and Price Projections

Market Overview

The clotrimazole market is poised for significant growth in the coming years, driven by several key factors. Clotrimazole, an antifungal medication, is widely used to treat various fungal infections such as vaginitis, athlete's foot, and otomycosis. Here is a comprehensive analysis of the market and its price projections.

Market Size and Growth

The global clotrimazole market is estimated to reach $4.2 billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period of 2024-2030[1][4].

Segmentation

By Type

The market is segmented into various forms of clotrimazole, including suppositories, tablets, creams, powders, and sprays. The cream segment is expected to hold the largest market share due to its widespread use in treating skin infections[1][4].

By Application

Clotrimazole is used to treat a range of fungal infections, including vaginitis, otomycosis, paronychia, and tinea of feet and hands. The vaginitis segment is anticipated to expand significantly during the forecast period[3][4].

By Sales Channel

The market is segmented by sales channels such as hospital pharmacies, drug store & retail pharmacy, and online pharmacies. Online pharmacies are emerging as the fastest-growing segment due to increased consumer preference for online shopping[1][4].

Geographical Analysis

North America

North America dominated the clotrimazole market in 2023, accounting for the largest share. This is attributed to the high prevalence of diseases such as athlete's foot and the presence of numerous pharmaceutical companies in the region[4].

Europe and APAC

Europe and the Asia-Pacific region also hold significant shares in the market, driven by the increasing incidence of fungal infections and the growing demand for antifungal treatments[1][4].

Key Drivers and Restraints

Rising Incidence of Fungal Infections

The increasing prevalence of fungal infections such as vaginitis, athlete's foot, and others is a major driver of the clotrimazole market. It is estimated that more than 70% of the U.S. population will develop tinea pedis (athlete's foot) during their lifetime[4].

Growing Application in Other Forms of Disease Treatment

Clotrimazole's application in treating various forms of fungal infections beyond traditional uses is also propelling market growth[1][4].

Innovation in Drug Delivery Systems

Advancements in drug delivery systems are creating new growth opportunities in the market. Innovative formulations and delivery methods enhance the efficacy and patient compliance of clotrimazole treatments[4].

Sizable Number of Side Effects and Substitutes

Despite the growth drivers, the market faces challenges from the sizable number of side effects associated with clotrimazole and the availability of substitutes. These factors can impact market growth negatively[1].

Price Projections

Current Pricing

The current prices of clotrimazole vary based on the form and quantity. For example, a 1% topical cream can cost between $10.76 and $14.52 for a 14-gram supply, while a 1% topical solution can cost between $17.60 and $33.81 for 10-30 milliliters[5].

Future Pricing Trends

Given the projected market growth, prices are likely to remain competitive. However, innovations in drug delivery systems and the increasing demand for antifungal treatments might lead to slight price increases. The overall market size and revenue growth suggest that prices will be balanced to ensure affordability and accessibility[1][4].

Key Market Players

The clotrimazole market is dominated by several key players, including:

  • Bayer AG
  • Erregierre SPA
  • Novartis AG
  • Amoli Organics Pvt. Ltd.
  • Guangzhou Hanpu Pharmaceutical Co., Ltd.
  • Manus Aktteva Biopharma LLP
  • Olon SpA
  • Ciron Group
  • GSK plc
  • Actiza Pharmaceutical Pvt. Ltd.[1][2]

These companies are focusing on expanding their product portfolios and business reach through strategic initiatives and innovations.

Technological and Regulatory Landscape

The market is influenced by technological advancements in drug delivery systems and regulatory approvals. Companies are investing in research and development to improve the efficacy and safety of clotrimazole products. Regulatory bodies play a crucial role in ensuring the quality and safety of these products, which can impact market dynamics[3].

Consumer Behavior and Market Trends

Consumer behavior is shifting towards online purchases, which is driving the growth of online pharmacies. Additionally, there is an increasing demand for over-the-counter (OTC) antifungal treatments, which is further boosting the market. The trend towards self-medication and the preference for convenient, effective treatments are key market drivers[1][4].

Key Takeaways

  • Market Growth: The clotrimazole market is projected to reach $4.2 billion by 2030, growing at a CAGR of 6.2% during the forecast period.
  • Segmentation: The cream segment holds the largest market share, and online pharmacies are the fastest-growing sales channel.
  • Geographical Dominance: North America dominates the market, followed by Europe and APAC.
  • Drivers: Rising incidence of fungal infections, growing application in other forms of disease treatment, and innovations in drug delivery systems.
  • Challenges: Side effects and availability of substitutes.

FAQs

  1. What is the projected market size of the clotrimazole market by 2030? The clotrimazole market is estimated to reach $4.2 billion by 2030[1][4].

  2. What is the CAGR of the clotrimazole market during the forecast period? The market is growing at a CAGR of 6.2% during the forecast period of 2024-2030[1][4].

  3. Which region dominates the clotrimazole market? North America dominates the clotrimazole market, accounting for the largest share[4].

  4. What are the key drivers of the clotrimazole market? The key drivers include the rising incidence of fungal infections, growing application in other forms of disease treatment, and innovations in drug delivery systems[1][4].

  5. Which segment holds the largest market share in the clotrimazole market? The cream segment holds the largest market share in the clotrimazole market[1][4].

Cited Sources:

  1. IndustryARC, "Clotrimazole Market - Forecast(2017-2025) Research Report"
  2. Valuates Reports, "Global Clotrimazole Market Insights, Forecast to ... "
  3. Cognitive Market Research, "Clotrimazole Market Report 2024 (Global Edition)"
  4. IndustryARC, "Clotrimazole Market - Forecast(2024 - 2030) - IndustryARC"
  5. Drugs.com, "Clotrimazole topical Prices, Coupons, Copay Cards & Patient ..."

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.